机构：[1]Fourth Hosp Hebei Med Univ, Breast Oncol Ctr, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[2]Fourth Hosp Hebei Med Univ, Funct Dept, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院
第一作者机构：[1]Fourth Hosp Hebei Med Univ, Breast Oncol Ctr, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Liu M. C.,Li Y.,Ma X.,et al.Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies[J].ANNALS OF ONCOLOGY.2020,31:S1253-S1253.doi:10.1016/j.annonc.2020.10.054.
APA：
Liu, M. C.,Li, Y.,Ma, X.,Zhang, L.,Yao, X....&Zhang, L..(2020).Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies.ANNALS OF ONCOLOGY,31,
MLA：
Liu, M. C.,et al."Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies".ANNALS OF ONCOLOGY 31.(2020):S1253-S1253
医学